将支气管热塑与严重喘的生物药物进行比较:系统审查和网络元分析
Khi Yung Fong1, Joseph J Zhao1, Nicholas L Syn1
1Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Respiratory medicine
|May 31, 2023
概括
支气管热塑术 (BT) 在严重喘管理中显示出与生物药物相比的有效性. 这项分析表明,BT是一种可行的替代品,可以改善生活质量和控制喘.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 进行元分析分析.
背景情况:
- 严重的喘缺乏支气管热塑术 (BT) 和生物疗法之间的直接比较.
- 随机对照试验 (RCT) 表明,BT具有良好的安全性和有效性.
- 了解BT的比较有效性对于治疗选择至关重要.
研究的目的:
- 为了比较支气管热整形 (BT) 与严重喘患者的生物疗法的疗效.
- 评估六个关键结果,包括喘控制,生活质量,恶化和皮质类固醇使用.
主要方法:
- 在PubMed,EMBASE和Cochrane中央注册表中进行了系统的文献搜索.
- 随机效应,Frequentist网络元分析 (NMA) 包括29个RCT (15,547名患者).
- 分析结果:喘控制问卷 (ACQ),喘生活质量问卷 (AQLQ),恶化,口服皮质类固醇剂量降低 (OCDR) 和早晨的最高呼气流量 (amPEF).
主要成果:
- 支气管热塑术 (BT) 与对照组相比,在经历≥1次喘恶化患者中显示出显著的减少.
- 与BT一起观察到ACQ和AQLQ得分,ampPEF和OCDR的显著改善.
- 间接比较显示,在所有分析结果中,BT和生物制剂之间没有显著差异.
结论:
- 支气管热塑术 (BT) 根据生活质量指标,证明了严重喘的生物疗法的非劣势性.
- BT为患有严重喘的患者提供了一个有前途的替代治疗选择.
- 进一步的对头试验可以提供最终的比较数据.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
319
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
319
01:20Asthma: Pathogenesis and Management
467
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467
01:26COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:17Drugs Used in Lower Respiratory Disorders: Overview
509
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
509